TILT Holdings Inc.

TILT

CA88688R1047

Pharmaceuticals

End-of-day quote NEO Exchange Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
0.04 ^CAD	0.00%		-11.11%	+33.33%

May. 15	Transcript : TILT Holdings Inc., Q1 2024 Earnings Call, May 15, 2024
Mar. 14	Transcript : TILT Holdings Inc., Q4 2023 Earnings Call, Mar 14, 2024

TILT Holdings Inc. Announces Appointment of Gary Santo to National Cannabis Roundtable Board of Directors

January 12, 2023 at 07:26 am EST

TILT Holdings Inc. announced its Chief Executive Officer ("CEO") Gary Santo has been appointed to the Board of Directors of the National Cannabis Roundtable ("NCR"). Founded in 2019, NCR is a non-partisan alliance of cannabis companies and ancillary services and solutions providers working to advance cannabis policy in the United States.

Latest news about TILT Holdings Inc.

Transcript : TILT Holdings Inc., Q1 2024 Earnings Call, May 15, 2024	May. 15
Transcript : TILT Holdings Inc., Q4 2023 Earnings Call, Mar 14, 2024	Mar. 14
TILT Holdings Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 14	CI
Tilt Holdings Announces New Brand Partnership with LEVEL to Bring Cannabis Tablets to Pennsylvania	Mar. 13	CI
Transcript : TILT Holdings Inc., Q3 2023 Earnings Call, Nov 13, 2023	Nov. 13
TILT Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
TILT Holdings Inc. Announces Board Changes	23-09-26	CI
TILT Holdings Inc. Appoints Tim Conder as Permanent CEO	23-09-26	CI
Transcript : TILT Holdings Inc., Q2 2023 Earnings Call, Aug 14, 2023	23-08-14
TILT Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
TILT Holdings Inc. Announces Board Changes	23-06-08	CI
TILT Holdings Inc. Announces Chief Financial Officer Changes	23-05-22	CI
TILT Holdings Inc. Announces Closing of an Offering of Up to USD 4.5 Million in Aggregate Principal Amount of Senior Secured Promissory Notes	23-05-16	CI
TILT Holdings Inc. announced that it has received $4 million in funding	23-05-15	CI
TILT Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Transcript : TILT Holdings Inc., Q1 2023 Earnings Call, May 15, 2023	23-05-15
TILT Holdings Inc. Announces Executive Changes	23-04-24	CI
TILT Holdings Inc. Announces Executive Changes	23-04-24	CI
TILT Holdings Inc. Announces Adam R. Draizin to its Committes	23-03-21	CI
TILT Holdings Inc. Assigns George Odden to the Audit Committee and Compensation Committee	23-03-21	CI
Transcript : TILT Holdings Inc., Q4 2022 Earnings Call, Mar 16, 2023	23-03-16
TILT Holdings Inc. Appoints George Odden as Board of Directors	23-03-14	CI
TILT Holdings Inc. announced that it has received $14.777458 million in funding	23-02-28	CI
TILT Holdings Inc. Enters into Licensing Agreement to Bring Thredz	23-02-28	CI
Doobie Announces Direct-To-Consumer Recreational Cannabis Delivery Partnership with Tilt Holdings	23-02-16	CI

Chart TILT Holdings Inc.

Duration

Period

More charts

Company Profile

TILT Holdings Inc. (TILT) is a Canada-based company. The Company is a business solutions provider to the global cannabis industry offering a diverse range of value-added products and services to industry participants. The Company operates through four segments: Cannabis, Accessories, Corporate, and Other. The Company offers technology, equipment, cultivation, and production services through its portfolio companies. It is organized in three business focuses: Consumer Devices & Packaged Goods, Cultivation and Production, and Retail. The Company is organized in various business units: inhalation technologies, cultivation, manufacturing, processing, brand development and retail. TILT services brands and cannabis retailers across 39 states in the Unites States as well as Canada, Israel, South America, and the European Union. The Company's subsidiaries include Commonwealth Alternative Care, Inc., White Haven RE, LLC, and Jupiter Research, LLC.

Sector

Pharmaceuticals

Calendar

2024-06-11 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for TILT Holdings Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.04

Average target price

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
TILT HOLDINGS INC.	+33.33%	11.39M
DONG-E-E-JIAO CO.,LTD.	+43.31%	6.19B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-16.99%	4.48B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+6.39%	3.29B
TASLY PHARMACEUTICAL GROUP CO., LTD	-13.10%	3.12B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-4.17%	2.5B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+45.47%	1.94B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-9.11%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-2.09%	1.64B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.50%	1.56B

Alternative Medicine